Table 3.
Outcomes | Female |
Male |
||
---|---|---|---|---|
β (95% CI) | P value | β (95% CI) | P value | |
Model 0 a | ||||
Social support | −0.088 (−0.052, 0.005) | 0.107 | −0.179 (−0.114, 0.005) | 0.071 |
LCS(Ref) | ||||
MCS | −0.138 (−2.187, 1.257) | 0.596 | −0.530 (−4.927, 0.881) | 0.171 |
HCS | 0.143 (−1.692, 2.866) | 0.613 | −0.524 (−4.973, 0.986) | 0.189 |
Social support × MCS | −0.185 (−0.056, 0.026) | 0.479 | 0.106 (−0.061, 0.079) | 0.792 |
Social support × HCS | −0.875 (−0.135, −0.029) | 0.002 | −0.383 (−0.103, 0.039) | 0.372 |
Model 1 b | ||||
Social support | −0.056 (−0.042, 0.012) | 0.281 | −0.181 (−0.114, 0.004) | 0.065 |
LCS(Ref) | ||||
MCS | −0.022 (−1.705, 1.558) | 0.929 | −0.617 (−5.199, 0.493) | 0.105 |
HCS | −0.001 (−2.187, 2.176) | 0.996 | −0.535 (−4.986, 0.911) | 0.175 |
Social support × MCS | −0.266 (−0.060, 0.018) | 0.283 | 0.237 (−0.048, 0.090) | 0.548 |
Social support × HCS | −0.610 (−0.108, −0.007) | 0.027 | −0.244 (−0.091, 0.050) | 0.566 |
β, standardized coefficient; CI, confidence interval; HCS, high character strengths; LCS, low character strengths; MCS, moderate character strengths.
Model 0: adjusted for no covariates.
Model 1: adjusted for age, education, marital status, residence, income, cancer type, time since diagnosis, treatment plan, and presence of comorbidities.